Research-use and scientific boundary statement
The operating boundaries that keep HumanTwin Bio scientifically, ethically and commercially accurate.
Current authorised use
HumanTwin Bio supports human digital-twin research, biomedical engineering, tissue and organ design, terrestrial and space-enabled biofabrication research, manufacturing-quality evidence and non-human preclinical translation.
Capabilities that remain disabled
- Human implantation and clinical product release
- Commercial release of engineered tissues or organs
- Autonomous diagnosis, prescribing or clinical decision-making
- Direct commands to printers, bioreactors, payloads, stations or spacecraft
- Unreviewed scientific-model execution presented as validated evidence
Space-environment accuracy
Stratospheric missions are treated as near-space qualification under approximately terrestrial gravity. Short-duration reduced gravity and sustained orbital microgravity are recorded as distinct environments and require appropriate matched controls.
Evidence maturity
Readiness gates, controlled transitions and quality records describe evidence maturity. They do not by themselves establish clinical safety, efficacy, manufacturability at commercial scale or regulatory approval.